Pharmacokinetic clinical trials

Explore recruiting pharmacokinetic clinical trials.

Recruiting pharmacokinetic studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pharmacokinetic trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study in healthy people to compare how 2 different high dose formulations of BI 1015550 are taken up in the body

Germany

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

A study in healthy women to test whether BI 1358894 influences the amount of a contraceptive in the blood

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

A study in healthy men to test how well different doses of BI 3802876 are tolerated

Belgium

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A study in healthy men to test how BI 1291583 is taken up by the body

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

A phase II, multicenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmacodynamics, and tolerability of osilodrostat in children and adolescent patients with Cushing's disease

France, Belgium, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, placebo-controlled, double-blind, multi-center, phase III trial to assess the efficacy and safety of trimodulin (BT588) in adult hospitalized subjects with CAP including COVID-19 pneumonia.

Belgium, Austria, Slovakia, Germany, Lithuania, Hungary +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pharmacokinetic trials by city

Pharmacokinetic in Toronto Pharmacokinetic in Vancouver Pharmacokinetic in Montreal Pharmacokinetic in Calgary Pharmacokinetic in Edmonton Pharmacokinetic in Ottawa Pharmacokinetic in Winnipeg Pharmacokinetic in Quebec City Pharmacokinetic in Hamilton Pharmacokinetic in Kitchener Pharmacokinetic in London Pharmacokinetic in Halifax Pharmacokinetic in New York Pharmacokinetic in Los Angeles Pharmacokinetic in Chicago Pharmacokinetic in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease